Feedback / Questions
Xervyteg (MaaT013) - MaaT Pharma
https://www.businesswire.com/news/home/20260914206480/en/MaaT-Pharma-Receives-Negative-CHMP-Trend-Vote-for-MaaT013-Xervyteg-Following-Re-Examination-for-its-Conditional-Marketing-Authorization-Application-in-Europe
Sep 15, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next